IMNN ▼ -4.1% - Imunon, Inc.
$IMNN - IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
24-SEP-2026 08:05 AM ET
Share this post
More filings for $IMNN
IMNN ▼ -6.4% - Imunon, Inc.Nov 2, 2026IMNN ▼ -4.0% - Imunon, Inc.Oct 21, 2026IMNN ▲ +8.0% - Imunon, Inc.Oct 8, 2026IMNN ▼ -1.4% - Imunon, Inc.Sep 29, 2026IMNN ▲ +5.2% - Imunon, Inc.Sep 10, 2026IMNN ▲ +5.7% - Imunon, Inc.Sep 9, 2026
View full $IMNN filing history →💬 Comments
Loading comments…
Leave a comment